Literature DB >> 34242031

Ivermectin: A Promising Therapeutic for Fighting Malaria. Current Status and Perspective.

Lovepreet Singh1, Kamaljit Singh1.   

Abstract

Finding new chemotherapeutic interventions to treat malaria through repurposing of time-tested drugs and rigorous design of new drugs using tools of rational drug design remains one of the most sought strategies at the disposal of medicinal chemists. Ivermectin, a semisynthetic derivative of avermectin B1, is among the efficacious drugs used in mass drug administration drives employed against onchocerciasis, lymphatic filariasis, and several other parasitic diseases in humans. In this review, we present the prowess of ivermectin, a potent endectocide, in the control of malaria through vector control to reduce parasite transmission combined with efficacious chemoprevention to reduce malaria-related fatalities.

Entities:  

Year:  2021        PMID: 34242031     DOI: 10.1021/acs.jmedchem.1c00498

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids.

Authors:  Lovepreet Singh; Diana Fontinha; Denise Francisco; Miguel Prudêncio; Kamaljit Singh
Journal:  Sci Rep       Date:  2022-01-12       Impact factor: 4.996

Review 2.  Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?

Authors:  Leon M T Dicks; Shelly M Deane; Matthew J Grobbelaar
Journal:  Probiotics Antimicrob Proteins       Date:  2022-02-25       Impact factor: 5.265

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.